PTC Therapeutics, Inc. (PTCT) FY2026 Q3 Balance Sheet

Published Source: Form 10-Q on SEC EDGAR filed (opens in a new tab)

As of 2026-09-30

Balance Sheet

Swipe to see the full flow
PTC Therapeutics, Inc. (PTCT) FY2026 Q3 Balance SheetBalance sheet as of 2026-09-30. The chart shows assets, liabilities and equity at that date.Current liabilities$776.08 MLiabilities$3.40 BCurrent assets$2.54 BNon-current liabilities$2.62 BAssets$3.21 BShareholders' deficit−$191.21 MNon-current assets$669.93 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSMarketable securitiesCash and cash equivalentsTrade and royalty receivables, netInventory, netPrepaid expenses and other current assetsIntangible assets, netGoodwillOperating lease ROU assetsFixed assets, netDeposits and other assetsAccounts payable and accrued expensesLiability for sale of future royalties- currentOperating lease liabilities- currentFinance lease liabilities- currentDeferred revenueLiability for sale of future royalties- noncurrentLong-term debtOperating lease liabilities- noncurrentOther long-term liabilitiesAccumulated deficitAdditional paid-in capitalAccumulated other comprehensive incomeCommon stock, $0.001 par value. Authorized 250,000,000 shares; issued and outstanding 83,535,767 shares at September 30, 2026. Authorized 250,000,000 shares; issued and outstanding 81,474,366 shares at December 31, 2025.Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesShareholders' deficitShareholders' deficitAccounts payable and accrued expensesAccounts payable and accrued expenses$440.81 MCurrent liabilitiesCurrent liabilities$776.08 MLiability for sale of future royalties- currentLiability for sale of future royalties- current$319.08 MOperating lease liabilities- currentOperating lease liabilities- current$11.21 MFinance lease liabilities- currentFinance lease liabilities- current$3.00 MDeferred revenueDeferred revenue$1.98 MLiabilitiesLiabilities$3.40 BMarketable securitiesMarketable securities$1.62 BCurrent assetsCurrent assets$2.54 BNon-current liabilitiesNon-current liabilities$2.62 BLiability for sale of future royalties- noncurrentLiability for sale of future royalties- noncurrent$1.99 BCash and cash equivalentsCash and cash equivalents$508.89 MAssetsAssets$3.21 BTrade and royalty receivables, netTrade and royalty receivables, net$238.07 MLong-term debtLong-term debt$536.27 MInventory, netInventory, net$109.33 MOperating lease liabilities- noncurrentOperating lease liabilities- noncurrent$85.55 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$62.47 MOther long-term liabilitiesOther long-term liabilities$14.50 MIntangible assets, netIntangible assets, net$443.69 MAccumulated deficitAccumulated deficit−$2.94 BGoodwillGoodwill$82.34 MShareholders' deficitShareholders' deficit−$191.21 MNon-current assetsNon-current assets$669.93 MOperating lease ROU assetsOperating lease ROU assets$72.95 MFixed assets, netFixed assets, net$49.33 MDeposits and other assetsDeposits and other assets$21.63 MAdditional paid-in capitalAdditional paid-in capital$2.74 BAccumulated other comprehensive incomeAccumulated other comprehensive income$2.55 MCommon stock, $0.001 par value. Authorized 250,000,000 shares; issued and outstanding 83,535,767 shares at September 30, 2026. Authorized 250,000,000 shares; issued and outstanding 81,474,366 shares at December 31, 2025.Common stock$82.00 K
Chart details

PTC Therapeutics, Inc. (PTCT) FY2026 Q3 Balance Sheet

Balance sheet as of 2026-09-30. The chart shows assets, liabilities and equity at that date.

Assets
3,207,715,000 US dollars
Current assets
2,537,784,000 US dollars
Non-current assets
669,931,000 US dollars
Liabilities
3,398,924,000 US dollars
Current liabilities
776,076,000 US dollars
Non-current liabilities
2,622,848,000 US dollars
Shareholders' deficit
negative 191,209,000 US dollars
Marketable securities
1,619,024,000 US dollars
Cash and cash equivalents
508,894,000 US dollars
Trade and royalty receivables, net
238,069,000 US dollars
Inventory, net
109,332,000 US dollars
Prepaid expenses and other current assets
62,465,000 US dollars
Intangible assets, net
443,686,000 US dollars
Goodwill
82,341,000 US dollars
Operating lease ROU assets
72,953,000 US dollars
Fixed assets, net
49,325,000 US dollars
Deposits and other assets
21,626,000 US dollars
Accounts payable and accrued expenses
440,811,000 US dollars
Liability for sale of future royalties- current
319,078,000 US dollars
Operating lease liabilities- current
11,212,000 US dollars
Finance lease liabilities- current
3,000,000 US dollars
Deferred revenue
1,975,000 US dollars
Liability for sale of future royalties- noncurrent
1,986,525,000 US dollars
Long-term debt
536,268,000 US dollars
Operating lease liabilities- noncurrent
85,554,000 US dollars
Other long-term liabilities
14,501,000 US dollars
Additional paid-in capital
2,741,391,000 US dollars
Accumulated other comprehensive income
2,553,000 US dollars
Common stock, $0.001 par value. Authorized 250,000,000 shares; issued and outstanding 83,535,767 shares at September 30, 2026. Authorized 250,000,000 shares; issued and outstanding 81,474,366 shares at December 31, 2025.
82,000 US dollars
Accumulated deficit
negative 2,935,235,000 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
PTC Therapeutics, Inc. (PTCT) FY2026 Q3 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!